TIEFENBACHER GROUP supports Post COVID-19 with Posaconazole against Black Fungus (Mucormycosis)

Tiefenbacher Group - A scientist wearing safety goggles and a lab coat closely observes equipment in a laboratory focused on patient-centric drug development, surrounded by scientific instruments and glassware.

TIEFENBACHER GROUP supports Post COVID-19 with Posaconazole tablets against Black Fungus (Mucormycosis) in IndiaBlack Fungus (Mucormycosis) is dramatically spreading in India connected to the extensive 2nd COVID-19 wave. The highly life-threatening disease usually occurs as a rare disease in immunocompromised patients. However, many patients who have survived their COVID-19 infection with the help of external […]